Longer Read
GORD guidance: managing heartburn and regurgitation
Studies show an increase in prevalence of gastro-oesophageal reflux disease (GORD). Reviewing the symptoms and guiding on the appropriate OTC treatments can help manage the condition. Leanne Philpott investigates It’s …
Empowering choice through contraception advice
Contraceptive counselling benefits both public and individual patient health. So, should pharmacists offer more in the way of contraceptive advice and care? Leanne Philpott reports Many young women may have …
Pen at the ready: recognising anaphylaxis and how to react
Anaphylaxis is a potentially fatal, severe allergic reaction. And it is on the rise. Knowing the signs and how to respond are vital, says Leanne Philpott. More than 4 million …
Withdrawal of pholcodine-containing cough medicines: the what, when and where to now?
An in-depth look at pholcodine, and why it was taken off the market. By Denise Hope, Dr Matt Zunk and Dr Santosh Rudrawar While the recent cancellation of the cough …
Steering an uncharted course for pharmacy
Lisa Nguyen stepped into uncharted territory when she founded Australia’s first cannabis-specialised dispensary. She talks about what drew her to specialise in this area, and the hot topics It’s one …
More than an ‘ouch’: managing pain in children
Pain is a major cause of upset for children, and their parents. Pharmacists can advise on the pharmacological and non-pharmacological treatments available There are many causes of pain in children. …
Helping in the fight against flu
Pharmacists can help their customers by addressing common flu and vaccine-related questions and assisting with symptomatic relief when flu strikes Early predictions for the flu season can be difficult, as …
Fake news and aggression in the pandemic
Researchers examine the rise of false information about Covid, as it happened…and what that meant for pharmacists and their safety This is the seventh and final article in a series …
Looking at harm minimisation
Naloxone, hazardous use of alcohol and treatment inequity: part two of our expert discussion of the latest in harm minimisation Why is the naloxone program not seeing wider take-up? Should …
Looking at harm minimisation
Methadone, buprenorphine, drug testing, naloxone and more: we discuss the latest views and opinions with a panel of experts Why is the naloxone program not seeing wider take-up? Should pharmacists …
The crackdown on vaping
Ahead of the May federal Budget, Health Minister Mark Butler announced a new crackdown on e-cigarettes. What does this mean for vapers, for smokers, and for pharmacists? Both vaping and …
The technology question
Pharmacy has suffered some body blows in recent months, but does technology offer options for the future that the profession can utilise to enhance healthcare and financial security? With community …
